AnaptysBio, Inc. Common Stock
$57.68
USD
Last updated on --.
24h volume482.16K
24h highest60.0100 USD
24h lowest57.0800 USD
24h Price movement-3.40%
ANAB recent prices
24 Hours
-3.40%-$2.030
30 days
-10.36%-$6.900
60 days
+3.99%+$2.290
90 days
+8.31%+$4.580
Key data
Previous close59.7100 USD
Market cap1.75B USD
Volume482.16K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.92000 USD
Net income (FY)-26.79M USD
Revenue (FY)232.39M USD
Last report date12 May 2026
About AnaptysBio, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)104.00
Revenue per employee (FY)2.23M USD
Net income per employee (FY)-257.57K USD
Listed onNasdaq
ANAB conversion tables
 |  |
|---|---|
| 0.5 ANAB | 28.84 USD |
| 1 ANAB | 57.68 USD |
| 5 ANAB | 288.4 USD |
| 10 ANAB | 576.8 USD |
| |
|---|---|
| 0.5 USD | 0.0086685 ANAB |
| 1 USD | 0.017337 ANAB |
| 5 USD | 0.086685 ANAB |
| 10 USD | 0.17337 ANAB |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ANAB is trading at $57.68, -3.40% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ANAB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ANAB is currently trading at $57.68, -3.40% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ANAB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ANAB's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ANAB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ANAB's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
AnaptysBio, Inc. Common Stock's market cap is currently 1.75B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume482.16K
24h highest60.0100 USD
24h lowest57.0800 USD
24h Price movement-3.40%
Start trade with ANAB Perpetual
Sign up to trade